IHS Chemical Week

People & Business :: Corporate Social Responsibility

Australia Warns of Tainted Batches of Heparin

10:24 AM MDT | April 7, 2008 | Alex Scott

Authorities in Australia have warned that four batches of AstraZeneca’s (AZ) blood-thinning drug heparin are contaminated. AZ is the latest in a series of companies, including Baxter Healthcare (Deerfield, IL), that has identified contamination in its heparin products, and all of the companies source their heparin active pharma ingredients (APIs) from China. Regulatory bodies in Denmark, France, Italy, Japan, Switzerland, and the U.S. say they have removed heparin from their markets to protect patients. Australia’s regulatory agency for...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa